Danaher Corp.
$237.47
-0.00 (-0.00%) Today
About
Danaher Corp. operates as a medical company, which designs, manufactures, and markets professional, medical, industrial and commercial products and services. It operates through the following segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines. The Diagnostics segment comprises of analytical instruments, reagents, consumables, software, and services that hospitals, physician's offices, reference laboratories, and other critical care settings use to diagnose disease and make treatment decisions. The Environmental & Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1969 and is headquartered in Washington, DC.
CEO
Thomas Patrick Joyce
Employees
60000
Headquarters
2200 Pennsylvania Avenue NW Washington, DC, 20037-1701
Founded
1969
Market Cap
Danaher Corp. News
Cepheid wins EUA for COVID-19, flu, RSV combination test
Sep 29, 2020
Cepheid announced today that it received FDA emergency use authorization for its Xpert Xpress SARS-CoV-2/Flu/RSV diagnostic test. The Danaher Corp. (NYSE:DHR) subsidiary’s rapid molecular diagnostic test for detecting the viruses causing COVID-19, Flu A, Flu B and RSV infections in a single patient can be used in tandem with any of Cepheid’s GeneXpert systems across the […]
PerkinElmer secures FDA emergency use authorizaiton for COVID-19 tests
Mar 25, 2020
PerkinElmer (NYSE:PKI) announced that the FDA granted it emergency use authorization (EUA) for its new coronavirus RT-PCR test. The Waltham, Mass.-based company said in a news release that clinical laboratories that are certified under the Clinical Laboratory Improvement Amendments (CLIA) can now immediately begin using the kit to detect the SARS-CoV-2 virus that causes COVID-19. PerkinElmer […]
Cepheid wins emergency use nod from FDA for bedside coronavirus test
Mar 23, 2020
Danaher Corp. (NYSE:DHR) subsidiary Cepheid announced that it received emergency use authorization from the FDA for its bedside Xpert Xpress SARS-CoV-2 test for detecting the virus causing the COVID-19 outbreak. The rapid molecular diagnostic test is designed to detect the SARS-CoV-2 virus causing coronavirus while operating on any of Cepheid’s GeneXpert systems worldwide, with a detection […]
Colfax slides on $3.2B DJO Global buy, plan to ditch air & gas handling biz
Nov 19, 2018
Colfax (NYSE:CFX) shares took a hit today after the industrial giant offered $3.15 billion to acquire orthopedics company DJO Global and said it plans to sell off its air & gas handling business. Vista, Calif.-based DJO, which is owned by a private equity consortium headed up by Blackstone, last week posted losses of -$29.5 million on sales of […]
General Electric to spin out GE Healthcare
Jun 26, 2018
General Electric (NYSE:GE) said today that it plans to spin out its GE Healthcare subsidiary as a stand-alone, publicly traded entity to focus on its aviation, power and renewable energy businesses. The Boston-based industrial conglomerate also said it’s planning an “orderly separation” from its 62.5% stake in BHGE oil and gas servicing and equipment unit over the next […]
